Skip to main content

Table 1 Source and timing of measures

From: Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin): study protocol for a randomized controlled trial

Outcome measures

Source

Timing

Recruitment

Post randomization

4 weeks

12 weeks

Need for additional intervention

Case report form

 

×

×

Additional interventions received

Participant questionnaire and case report form

 

×

×

Pain (numeric rating scale)

Participant questionnaire

×

×

 

Health profile and status (SF36, EQ5D)

Participant questionnaire

×

×

×

Use of analgesics

Participant questionnaire

 

×

 

Adverse events

Participant questionnaire

 

×

×

Time to passage of stone

Participant questionnaire and case report form

 

×

×

NHS primary and secondary healthcare use

Participant questionnaire and case report form

  

×

Participant out of pocket costs

Participant questionnaire

  

×

  1. EQ5D, European Quality of Life, 5 Dimensions; SF36, Short Form (36) Health Survey.